ScienceQuiet 28d · day 31
Trump's FDA pick previously called for 'conservative-based' science journals
Heidi Overton, nominated to lead the FDA, outlined a vision in 2023 for alternate research publishing systems aligned with conservative policy.
What to know
- Heidi Overton, Trump's FDA nominee, proposed in 2023 creating new academic journals and research funding systems explicitly designed to support conservative policy goals.
- She argued that conservatives should stop trying to work within existing academic publishing systems and instead build 'alternate systems' for publishing research.
- The comments surfaced after her nomination and have been amplified by Stand Up for Science, a nonprofit focused on resisting political interference in federal research agencies.
“President Donald Trump's nominee to lead the Food and Drug Administration previously called on conservatives to create new academic journals and to fund science that would explicitly back right-wing policy goals.”
Adam Kovac, Scientific American reporter · Scientific American · Aug 24
Heidi Overton Trump's FDA nominee
Donald Trump U.S. PresidentStand Up for Science Nonprofit advocacy group
The record 3 articles and posts · last 30 days
- summary covers to here · Aug 25, 2:51 PM · 1 piece above arrived after